Ad26.ZEBOV/MVA-BN-Filo
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Ad26.ZEBOV/MVA-BN-Filo, covering 2021-05-12 to 2022-03-07. Get the full timeline:
Most recent: Clinical Trial Update: Safety, Tolerability and Immunogenicity Study of 3 Prime-boost Regimens for Ebola Vaccines Ad26.ZEBOV/MVA-BN-Filo in Healthy Adults, Children and Human Immunodeficiency Virus Positive (HIV+) Adults [Phase 2]